Biotech Investors & VC Firms in Global
642 firms in this list, with a median first check of $500K. 156 of them lead rounds. Generated from verified public data and updated continuously.
Stone Bridge Ventures
SeoulSeed–Late Stage$1.4M – $19M
Lichen Ventures
BaltimoreSeed–Late Stage$200K
2 people
MaRS
TorontoPre-Seed–Late Stage
1 person
Rockley Group
OxfordGrowth
3 people
TAYA Venture Capital
New Taipei CityPre-Seed–Growth
5 people
Healthspan Capital
OxfordSeed–Series A$5K
2 people
Global Health Investment Corporation
New YorkSeed–Series B
4 people
Baidu Ventures
BeijingPre-Seed–Growth$1.4M – $145M
Vocal Ventures
Pre-Seed–Seed
PacBridge Capital Partners
Hong KongSeed–Growth
5 people
PrimeStreet Capital
Bangkok
5 people
Relia Health
OntarioPre-Seed–Series A
5 people
Infinity Group
Tel AvivGrowth$1M – $10M
2 people
MCI Capital S.A.
WarsawGrowth–Late Stage$27M – $108M
2 people
VNK Capital
Limassol
2 people
Cancer Focus
HoustonPre-Seed–Series A
4 people
Cerberus Capital Management
New YorkPre-Seed–Seed
3 people
Syngenta Group Ventures
DurhamSeed–Growth$500K – $5M
6 people
Trinity Innovation Bioventure Singapore
SingaporeSeed–Late Stage
3 people
Tarnagulla Ventures
MelbournePre-Seed–Series A
2 people
Brandon BioCatalyst
MelbournePre-Seed–Series A
1 person
Embryo Ventures
LondonPre-Seed–Series A
1 person
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
Syno Capital, LLC
New YorkSeries A
4 people
Related lists
Investors & VC Firms in North America (14123)Investors & VC Firms in United States (13261)Investors & VC Firms in Europe (5574)Crypto & Web3 Investors & VC Firms (4829)Investors & VC Firms in Global (4159)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3768)Fintech Investors & VC Firms (3725)Investors & VC Firms in Asia-Pacific (3573)Healthtech Investors & VC Firms (3414)
Data sourced from public filings and firms' own websites — see our methodology.







.jpg)






































